Albany Molecular Research : AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M Wes...	17-01-18
Albany Molecular Research : AMRI Names Michael Mulhern as Chief Executive Officer	04-01-18
Albany Molecular Research : AMRI’s SSCI Implements Next-Generation Analytical Instrumentation to Further Strengthen...	19-12-17
Albany Molecular Research : AMRI Doubles Bulk API Aseptic Manufacturing Capacity	30-11-17
Albany Molecular Research : AMRI Presents Expanded Capabilities at 2017 AAPS Annual Meeting	09-11-17

Managers	Titel	Leeftijd	Van
Philip W Macnabb CEO	Chief Executive Officer	-	01-05-23
Meera Khullar CMP	Compliance Officer	-	01-03-19
Prakash Pandian CTO	Chief Tech/Sci/R&D Officer	-	01-06-18

Besturend	Titel	Leeftijd	Van
Dean Mihas BRD	Director/Board Member	57	-
Sean Cunningham BRD	Director/Board Member	48	-
William McMullan BRD	Director/Board Member	46	-

Bedrijfsprofiel

Sector

	Vaira. 1 jan.	Kapi.
MODERNA, INC.	+43,36%	54,64 mld.
IQVIA HOLDINGS INC.	-5,31%	39,92 mld.
LONZA GROUP AG	+37,52%	38,82 mld.
ICON PUBLIC LIMITED COMPANY	+14,75%	26,86 mld.
CELLTRION, INC.	-12,56%	26,22 mld.
ALNYLAM PHARMACEUTICALS, INC.	-22,45%	18,78 mld.
UNITED THERAPEUTICS CORPORATION	+25,12%	12,21 mld.
BIO-TECHNE CORPORATION	+0,04%	12,16 mld.
MEDPACE HOLDINGS, INC.	+26,04%	11,94 mld.